Tadalafil Tablet, Coated
Product Images NDC 62332-178

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 62332-178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 5 (Tadalafil 5figure)

The text describes a graph showing the mean changes in IPSS (International Prostate Symptom Score) in patients with BPH (benign prostatic hyperplasia) treated with tadalafil tablets of 5 mg dosage or placebos. The changes are displayed based on the treatment duration of up to 12 weeks.*

FDA Label Image

Figure 6 (Tadalafil 6figure)

This appears to be a graph or chart displaying the change from baseline in IPSS (International Prostate Symptom Score) total score in BPH (Benign Prostatic Hyperplasia) patients treated with Tadalafil Tablet 5 mg over a duration of 12 weeks. The X-axis represents the duration of treatment in weeks, and the Y-axis represents the mean IPSS changes at each visit. However, without the actual graph or chart, it is difficult to provide a more detailed description.*

FDA Label Image

Figure 7 (Tadalafil 7figure)

The text describes a graph showing the mean total IPSS changes by visit in BPH patients taking Tadalafil Tablet with Finasteride. The x-axis in the graph represents the number of weeks of therapy, while the y-axis represents the least-squares treatment difference and the LS mean change from baseline. There are two groups being compared, Tadalafil/Finasteride and Placebo/Finasteride. The text also indicates that there is statistical significance (p<0.05) in the LS mean change from baseline for the Tadalafil/Finasteride group compared to the Placebo/Finasteride group.*

FDA Label Image

Figure 8 (Tadalafil 8figure)

The text describes a chart showing the change in IPSS total score in ED/BPH patients using Tadalafil Tablet 5mg and placebo over a period of 12 weeks. The chart shows that there is a significant difference in IPSS total score between the two groups (p<0.01). The text indicates that the chart is from "Study L".*

FDA Label Image

Figure 1 (Tadalafil Figure1)

FDA Label Image

Figure 2 (Tadalafil Figure2)

FDA Label Image

Figure 3 (Tadalafil Figure3)

This appears to be a table or graph displaying the results of a study comparing different doses and timings of tadalafil and doxazosin on blood pressure. The table shows the dosages and timings administered, as well as the resulting blood pressure measurements.*

FDA Label Image

Figure 4 (Tadalafil Figure4)

This is a graph that shows the concentration of Tadalafil in plasma in micrograms per liter (ug/L) at different time intervals (in hours) after the administration of different doses. The graph compares the concentrations achieved by a single 20-mg Tadalafil dose, a single 5-mg Tadalafil dose, and a once-daily 5-mg Tadalafil dose after five consecutive days of administration.*

FDA Label Image

Tadalafil mg5

Product description: This text consists of information about a medication named "oo smarwens Tafalafil Tablets, USP" with the National Drug Code (NDC) 62332-178-30. The format of the information appears to be a label or packaging of the medication. There is also a code on the label, GTIN: 0362332178308, and information related to the manufacturer, "Pramac il Lintad". There is no further useful information in this text.*

FDA Label Image

Tadalafil Strength10

Not available. The text appears to be a combination of random letters, numbers, and symbols that do not form a coherent description or piece of information.*

FDA Label Image

Tadalafil Strength20

This is a description for Tadalafil Tablets, USP manufactured by Wbl Praramsasials. The tablets come in a bottle with NDC 62332-180-30 and should be stored at room temperature. The recommended dosage and other usage instructions are illegible. The product is available for prescription only.*

FDA Label Image

Tadalafil Strength25mg

FDA Label Image

Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.